Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind trial of S-474474 in essential hypertension patients non-responsive to irbesartan
jRCT2080221107Phase 3
- Sponsor
- Shionogi & Co., Ltd.
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of irbesartan + trichlormethiazide in essential hypertension, sponsored by Shionogi & Co., Ltd.
02
Drugs
irbesartan + trichlormethiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on jRCT2080221107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221107.